SI0871656T1 - Dolastatin derivatives, their preparation and use - Google Patents

Dolastatin derivatives, their preparation and use

Info

Publication number
SI0871656T1
SI0871656T1 SI9630550T SI9630550T SI0871656T1 SI 0871656 T1 SI0871656 T1 SI 0871656T1 SI 9630550 T SI9630550 T SI 9630550T SI 9630550 T SI9630550 T SI 9630550T SI 0871656 T1 SI0871656 T1 SI 0871656T1
Authority
SI
Slovenia
Prior art keywords
preparation
dolastatin derivatives
dolastatin
derivatives
Prior art date
Application number
SI9630550T
Other languages
English (en)
Slovenian (sl)
Inventor
Andreas Haupt
Franz Emling
Cynthia A. Romerdahl
Original Assignee
Abbott Gbmh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gbmh & Co. Kg filed Critical Abbott Gbmh & Co. Kg
Publication of SI0871656T1 publication Critical patent/SI0871656T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI9630550T 1995-06-07 1996-06-03 Dolastatin derivatives, their preparation and use SI0871656T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/472,453 US5831002A (en) 1992-05-20 1995-06-07 Antitumor peptides
PCT/EP1996/002393 WO1996040752A1 (en) 1995-06-07 1996-06-03 Novel dolastatin derivatives, their preparation and use
EP96918661A EP0871656B1 (en) 1995-06-07 1996-06-03 Dolastatin derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
SI0871656T1 true SI0871656T1 (en) 2003-08-31

Family

ID=23875567

Family Applications (2)

Application Number Title Priority Date Filing Date
SI9630539T SI0832104T1 (en) 1995-06-07 1996-06-03 Dolastatin derivatives, their preparation and use
SI9630550T SI0871656T1 (en) 1995-06-07 1996-06-03 Dolastatin derivatives, their preparation and use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI9630539T SI0832104T1 (en) 1995-06-07 1996-06-03 Dolastatin derivatives, their preparation and use

Country Status (33)

Country Link
US (1) US5831002A (ko)
EP (2) EP0871656B1 (ko)
JP (2) JP4221062B2 (ko)
KR (2) KR100437985B1 (ko)
CN (2) CN1182154C (ko)
AR (2) AR003427A1 (ko)
AT (2) ATE224910T1 (ko)
AU (2) AU725164B2 (ko)
BG (2) BG102125A (ko)
BR (2) BR9609423A (ko)
CA (2) CA2219818C (ko)
CO (2) CO4700527A1 (ko)
CZ (2) CZ293682B6 (ko)
DE (2) DE69623992T2 (ko)
DK (2) DK0871656T3 (ko)
ES (2) ES2186783T3 (ko)
HR (2) HRP960277A2 (ko)
HU (2) HU228073B1 (ko)
IL (2) IL122216A (ko)
MX (2) MX9709146A (ko)
MY (2) MY119042A (ko)
NO (2) NO318384B1 (ko)
NZ (2) NZ310443A (ko)
PL (2) PL185762B1 (ko)
PT (2) PT832104E (ko)
RO (2) RO119783B1 (ko)
SI (2) SI0832104T1 (ko)
SK (1) SK282466B6 (ko)
TR (2) TR199701544T1 (ko)
TW (2) TW508357B (ko)
UA (2) UA46775C2 (ko)
WO (2) WO1996040752A1 (ko)
ZA (2) ZA964710B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
JP2002538151A (ja) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カテプシンの可逆的インヒビターとして有用な化合物
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2445591A1 (en) 2001-04-27 2002-11-07 The Procter & Gamble Company Nitrogen heterocyclic compounds and compositions for controlling biofilms
AU2002359792A1 (en) * 2001-12-18 2003-06-30 Proteologics, Inc. Methods and compositions for the inhibition of viral release
WO2003072754A2 (en) * 2002-02-27 2003-09-04 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
WO2006013552A2 (en) 2004-08-02 2006-02-09 Ramot At Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
WO2006122408A1 (en) 2005-05-18 2006-11-23 Aegera Therapeutics Inc. Bir domain binding compounds
EP1924245A2 (en) * 2005-08-19 2008-05-28 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Topical formulations of histone deacetylase inhibitors and methods of using the same
US10004828B2 (en) * 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
JP5419685B2 (ja) 2006-05-16 2014-02-19 ファーマサイエンス・インコーポレイテッド Ｉａｐｂｉｒドメイン結合タンパク質
JP5452223B2 (ja) * 2006-07-24 2014-03-26 テトラロジック ファーマシューティカルズ コーポレーション Ｉａｐ阻害剤
AU2008239730B2 (en) 2007-04-12 2011-10-06 Scinopharm Taiwan, Ltd. Process for making galantamine
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8283372B2 (en) 2009-07-02 2012-10-09 Tetralogic Pharmaceuticals Corp. 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
EP2534170B1 (en) 2010-02-12 2017-04-19 Pharmascience Inc. Iap bir domain binding compounds
CA2822556A1 (en) 2010-12-30 2012-07-05 Enanta Pharmaceuticals, Inc Macrocyclic hepatitis c serine protease inhibitors
JP2014506255A (ja) 2010-12-30 2014-03-13 エナンタ ファーマシューティカルズ インコーポレイテッド フェナントリジン大環状ｃ型肝炎セリンプロテアーゼ阻害剤
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
ES2690993T3 (es) 2011-05-27 2018-11-23 Ambrx, Inc. Composiciones que contienen y métodos que implican derivados de dolastatina enlazados con aminoácidos no naturales y usos de los mismos
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
WO2023033129A1 (ja) 2021-09-03 2023-03-09 東レ株式会社 癌の治療及び／又は予防用医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
ATE190983T1 (de) * 1991-08-09 2000-04-15 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate
RU2116312C1 (ru) * 1992-05-20 1998-07-27 Басф Акциенгезельшафт Производные пептида или их соли, фармацевтическая композиция
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters

Also Published As

Publication number Publication date
TW424096B (en) 2001-03-01
EP0871656A1 (en) 1998-10-21
MY124487A (en) 2006-06-30
US5831002A (en) 1998-11-03
NO975711D0 (no) 1997-12-05
PL185762B1 (pl) 2003-07-31
AU725164B2 (en) 2000-10-05
EP0832104B1 (en) 2002-09-04
CZ376397A3 (cs) 1998-06-17
AU6124296A (en) 1996-12-30
HU228071B1 (hu) 2012-09-28
CZ376597A3 (cs) 1998-06-17
CN1182154C (zh) 2004-12-29
PL323723A1 (en) 1998-04-14
MX9709146A (es) 1998-03-31
BG102125A (en) 1998-09-30
CA2219818A1 (en) 1996-12-19
DE69623472D1 (de) 2002-10-10
ATE224910T1 (de) 2002-10-15
EP0871656B1 (en) 2002-09-25
IL122216A0 (en) 1998-04-05
KR19990022582A (ko) 1999-03-25
CO4700527A1 (es) 1998-12-29
NO317670B1 (no) 2004-11-29
HUP9801910A3 (en) 1999-06-28
NO975710L (no) 1998-02-02
JPH11504653A (ja) 1999-04-27
CO4700526A1 (es) 1998-12-29
PL323726A1 (en) 1998-04-14
CZ293682B6 (cs) 2004-07-14
HU228073B1 (hu) 2012-09-28
JP4221062B2 (ja) 2009-02-12
BR9609423A (pt) 1999-06-29
PL185763B1 (pl) 2003-07-31
HUP9801817A3 (en) 1999-06-28
DK0871656T3 (da) 2003-01-27
ZA964710B (en) 1997-12-08
RO119783B1 (ro) 2005-03-30
HRP960277A2 (en) 1997-10-31
EP0832104A1 (en) 1998-04-01
ES2188759T3 (es) 2003-07-01
CA2219818C (en) 2008-05-20
AU725170B2 (en) 2000-10-05
ZA964711B (en) 1997-12-08
CN1187199A (zh) 1998-07-08
PT871656E (pt) 2002-12-31
JP3957751B2 (ja) 2007-08-15
MY119042A (en) 2005-03-31
AU6124196A (en) 1996-12-30
UA46776C2 (uk) 2002-06-17
KR100437986B1 (ko) 2004-09-18
BR9609424A (pt) 2000-03-28
ES2186783T3 (es) 2003-05-16
UA46775C2 (uk) 2002-06-17
KR19990022583A (ko) 1999-03-25
DE69623472T2 (de) 2003-08-21
HUP9801817A2 (hu) 1998-11-30
IL122215A0 (en) 1998-04-05
HUP9801910A2 (hu) 1999-01-28
SK282466B6 (sk) 2002-02-05
CA2219819C (en) 2008-05-20
DE69623992T2 (de) 2003-05-22
NZ310443A (en) 1999-10-28
BG102152A (en) 1998-09-30
SI0832104T1 (en) 2003-08-31
TR199701544T1 (xx) 1998-03-21
TR199701545T1 (xx) 1998-04-21
NO975711L (no) 1998-01-30
JPH11504652A (ja) 1999-04-27
KR100437985B1 (ko) 2004-09-18
NO975710D0 (no) 1997-12-05
NZ310444A (en) 1999-11-29
MX9709147A (es) 1998-03-31
WO1996040752A1 (en) 1996-12-19
WO1996040751A1 (en) 1996-12-19
CA2219819A1 (en) 1996-12-19
HRP960257A2 (en) 1998-02-28
DE69623992D1 (de) 2002-10-31
IL122216A (en) 2002-02-10
CN1182153C (zh) 2004-12-29
PT832104E (pt) 2002-12-31
ATE223431T1 (de) 2002-09-15
AR003427A1 (es) 1998-08-05
IL122215A (en) 2001-08-26
NO318384B1 (no) 2005-03-14
CZ293683B6 (cs) 2004-07-14
AR003136A1 (es) 1998-07-08
TW508357B (en) 2002-11-01
SK165397A3 (en) 1998-10-07
RO118953B1 (ro) 2004-01-30
CN1187198A (zh) 1998-07-08
DK0832104T3 (da) 2003-01-06

Similar Documents

Publication Publication Date Title
HUP9801817A3 (en) Dolastatin derivatives, their preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
EP0728749A3 (en) Triazine derivatives, their preparation and their application
EP0710667B8 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
HUP9801139A3 (en) Polysiloxane-polyol macromers, their preparation and their use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL117807A0 (en) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
AU7095296A (en) Phosphorylamides, their preparation and use
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
GR3031710T3 (en) Oxazolidinone derivatives, their preparation and therapeutical use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
SG49960A1 (en) Dyes, processes for their preparation and their use
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
EP0744125A3 (en) Iodine complex and its application
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use